The implementation of artificial intelligence (AI) assistance in pathology has been shown to significantly reduce the risk of immunohistochemistry (IHC) use per detected case of sentinel node (SN) metastasis, resulting in cost savings and time efficiency. In a single-center prospective trial, AI-assisted pathologists spent less time assessing hematoxylin and eosin (HE) slides of SN specimens and had higher sensitivity and negative predictive values for detecting micrometastases and macrometastases. The study also found that AI assistance prevented the use of IHC for detecting micrometastases and reduced the cost of IHC use per detected case of SN metastasis.
AI Assistance in Pathology Reduces Costs and Time
AI-assisted pathologists spent significantly less time assessing HE slides of SN specimens, with an average time of 3 minutes and 41 seconds compared to 6 minutes and 4 seconds for unassisted pathologists.
TOP STORIES
Obama stresses Democrats must prioritize AI safety and economic strategy …
Amodei’s call for caution in AI development highlights the need for safety and alignment …
Sony Music and Warner Music have sued Anthropic, accusing it of copyright infringement in AI training …
Huang believes Nvidia’s position in AI will lead to another year of record growth …
Anthropic’s report reveals a surge in distillation attacks by Chinese AI firms on U.S. models …
AI agents’ autonomy poses significant risks, as demonstrated by a recent breach …
